519
Views
113
CrossRef citations to date
0
Altmetric
Review

Procalcitonin for guidance of antibiotic therapy

, , , &
Pages 575-587 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Wonyoung Heo & Hyung-Doo Park. (2021) Analytical and clinical performance of the Advansure i3 procalcitonin assay. Scandinavian Journal of Clinical and Laboratory Investigation 81:7, pages 546-551.
Read now
Philipp Schuetz, Rebekka Bolliger, Meret Merker, Mirjam Christ-Crain, Daiana Stolz, Michael Tamm, Charles E Luyt, Michel Wolff, Stefan Schroeder, Vandack Nobre, Konrad Reinhart, Angela Branche, Pierre Damas, Maarten Nijsten, Rodrigo O. Deliberato, Alessia Verduri, Bianca Beghé, Bin Cao, Yahya Shehabi, Jens-Ulrik S. Jensen, Albertus Beishuizen, Evelien de Jong, Matthias Briel, Tobias Welte & Beat Mueller. (2018) Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Expert Review of Anti-infective Therapy 16:7, pages 555-564.
Read now
Philipp Schuetz, Celine Bretscher, Luca Bernasconi & Beat Mueller. (2017) Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis. Expert Review of Molecular Diagnostics 17:6, pages 593-601.
Read now
Caspar Corti, Markus Fally, Andreas Fabricius-Bjerre, Katrine Mortensen, Birgitte Nybo Jensen, Helle F Andreassen, Celeste Porsbjerg, Jenny Dahl Knudsen & Jens-Ulrik Jensen. (2016) Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1381-1389.
Read now
Ligia SCF Rabello, Thiago Lisboa, Marcio Soares & Jorge IF Salluh. (2015) Personalized treatment of severe pneumonia in cancer patients. Expert Review of Anti-infective Therapy 13:11, pages 1319-1324.
Read now
Sebastian Haubitz, Beat Mueller & Philipp Schuetz. (2013) Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies. Expert Review of Respiratory Medicine 7:2, pages 145-157.
Read now
Sofya Tokman, Philipp Schuetz & Stephen Bent. (2011) Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations. Expert Review of Anti-infective Therapy 9:6, pages 727-735.
Read now

Articles from other publishers (105)

Jaume Baldirà, Juan Carlos Ruiz-Rodríguez, Adolfo Ruiz-Sanmartin, Luis Chiscano, Alejandro Cortes, Diego Ángeles Sistac, Roser Ferrer-Costa, Inma Comas, Yolanda Villena, Maria Nieves Larrosa, Juan José González-López & Ricard Ferrer. (2023) Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6. Biomedicines 11:8, pages 2149.
Crossref
Fatima Meraj, Sumera Shaikh, Sidra Maqsood, Fatima Kanani, Hamza Khan & Saba Jamal. (2023) Monocyte Distribution Width, a Novel Biomarker for Early Sepsis Screening and Comparison with Procalcitonin and C-Reactive Protein. Journal of Laboratory Physicians 15:02, pages 294-299.
Crossref
Sai Sreeya Gude, Shravya Venu Gopal, Harshita Marasandra Ramesh, Sravya Vuppalapati, Nikhil Chowdary Peddi & Sai Sravya Gude. (2022) Unraveling the Nature of Antibiotics: Is It a Cure or a New Hurdle to the Patient Treatment?. Cureus.
Crossref
Walid A. Ali, Naglaa S. Bazan, Ahmed A. Elberry & Raghda R. S. Hussein. (2021) A randomized trial to compare procalcitonin and C-reactive protein in assessing severity of sepsis and in guiding antibacterial therapy in Egyptian critically ill patients. Irish Journal of Medical Science (1971 -) 190:4, pages 1487-1495.
Crossref
M. A. Kharitonov, V. V. Salukhov, E. V. Kryukov, M. B. Patsenko, Yu. V. Rudakov, A. B. Bogomolov, V. V. Ivanov & A. A. Minakov. (2021) Viral pneumonia: a new look at an old problem (review). Meditsinskiy sovet = Medical Council:16, pages 60-77.
Crossref
Sen-Kuang Hou, Hui-An Lin, Shao-Chun Chen, Chiou-Feng Lin & Sheng-Feng Lin. (2021) Monocyte Distribution Width, Neutrophil-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio Improves Early Prediction for Sepsis at the Emergency. Journal of Personalized Medicine 11:8, pages 732.
Crossref
Andrea Ticinesi, Antonio Nouvenne, Beatrice Prati, Loredana Guida, Alberto Parise, Nicoletta Cerundolo, Chiara Bonaguri, Rosalia Aloe, Angela Guerra & Tiziana Meschi. (2021) The Clinical Significance of Procalcitonin Elevation in Patients over 75 Years Old Admitted for COVID-19 Pneumonia. Mediators of Inflammation 2021, pages 1-10.
Crossref
Nicholas Andrew Bradley, Campbell Roxburgh, Faisel Khan & Graeme Guthrie. (2021) Postimplantation syndrome in endovascular aortic aneurysm repair – a systematic review. Vasa 50:3, pages 174-185.
Crossref
Devki Nandan, Manju Nimesh, Sushil Kumar, Lucky Manik, J Sudarshan & Nandini Duggal. (2021) Serum procalcitonin as an early inflammatory marker in pediatric ventilator-associated pneumonia: A prospective observational study. Journal of Pediatric Critical Care 8:5, pages 229.
Crossref
Minjing Liao, Jiao Zheng, Ye Xu, Yilan Qiu, Chuan Xia, Zhihong Zhong, Lihui Liu, Hongrong Liu, Rushi Liu & Songyue Liang. (2021) Development of magnetic particle-based chemiluminescence immunoassay for measurement of human procalcitonin in serum. Journal of Immunological Methods 488, pages 112913.
Crossref
Woo Jin Jung, Jung-Hyuck Park, Sungwoo Goo, Jung-woo Chae, JaeWoo Kim, Sooyoung Shin & Hwi-yeol Yun. (2021) Dose Optimization of Vancomycin Using a Mechanism-based Exposure–Response Model in Pediatric Infectious Disease Patients. Clinical Therapeutics 43:1, pages 185-194.e16.
Crossref
Jaume Baldirà, Juan Carlos Ruiz-Rodríguez, Darius Cameron Wilson, Adolf Ruiz-Sanmartin, Alejandro Cortes, Luis Chiscano, Roser Ferrer-Costa, Inma Comas, Nieves Larrosa, Anna Fàbrega, Juan José González-López & Ricard Ferrer. (2020) Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in-hospital sepsis code. Annals of Intensive Care 10:1.
Crossref
Gang Wang, Yong Wan, Guanfeng Lin, Zhixiong Li, Zhining Dong & Tiancai Liu. (2020) Development of a novel chemiluminescence immunoassay for the detection of procalcitonin. Journal of Immunological Methods 484-485, pages 112829.
Crossref
Pedro Povoa & Andre C. Kalil. (2020) Any Role for Biomarker-Guide Algorithms in Antibiotic Stewardship Programs?*. Critical Care Medicine 48:5, pages 775-777.
Crossref
Yu. V. Dinikina, Yu. K. Toshina & M. B. Belogurova. (2020) diagnostic utility of procalcitonin in children with infectious complications during chemotherapy-induced neutropenia: single center experience, literature review. Oncohematology 15:1, pages 65-72.
Crossref
Elena Aloisio, Alberto Dolci & Mauro Panteghini. (2019) Procalcitonin: Between evidence and critical issues. Clinica Chimica Acta 496, pages 7-12.
Crossref
Philipp Schuetz, Albertus Beishuizen, Michael Broyles, Ricard Ferrer, Gaetan Gavazzi, Eric Howard Gluck, Juan González del Castillo, Jens-Ulrik Jensen, Peter Laszlo Kanizsai, Andrea Lay Hoon Kwa, Stefan Krueger, Charles-Edouard Luyt, Michael Oppert, Mario Plebani, Sergey A. Shlyapnikov, Giulio Toccafondi, Jennifer Townsend, Tobias Welte & Kordo Saeed. (2019) Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clinical Chemistry and Laboratory Medicine (CCLM) 57:9, pages 1308-1318.
Crossref
Takanori Akagi, Nobuhiko Nagata, Kentaro Wakamatsu, Taishi Harada, Hiroyuki Miyazaki, Satoshi Takeda, Shinichiro Ushijima, Takashi Aoyama, Yuji Yoshida, Hiroshi Yatsugi, Kenji Wada, Yusuke Ueda, Masaki Fujita & Kentaro Watanabe. (2019) Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence. The American Journal of the Medical Sciences 358:1, pages 33-44.
Crossref
Bo-Sun Shim, Young-Hoon Yoon, Jung-Youn Kim, Young-Duck Cho, Sung-Jun Park, Eu-Sun Lee & Sung-Hyuk Choi. (2019) Clinical Value of Whole Blood Procalcitonin Using Point of Care Testing, Quick Sequential Organ Failure Assessment Score, C-Reactive Protein and Lactate in Emergency Department Patients with Suspected Infection. Journal of Clinical Medicine 8:6, pages 833.
Crossref
Xinshui Wang, Yanbei Sun & Xiaonan Shao. (2019) Predictive value of procalcitonin for infection of patients with type‑2 diabetes mellitus. Experimental and Therapeutic Medicine.
Crossref
Johnny Gutierrez, Alessander O Guimaraes, Nicholas Lewin-Koh, Aklile Berhanu, Min Xu, Yi Cao, Janice Kim, Donghong Yan, Joanna K Chang, Jason B Dinoso, Catherine A Koss, Angelo Clemenzi-Allen, Henry F Chambers, Melicent C Peck, Amos Baruch & Carrie M Rosenberger. (2019) Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases 6:4.
Crossref
Lijuan Jiang, Xiaonan Shao, Wei Xing & Yanbei Sun. (2019) Biomarkers and risk factors for sepsis in stage 5 chronic kidney disease: a retrospective case–control study. International Urology and Nephrology 51:4, pages 691-698.
Crossref
Kyeongman Jeon, Jae Kyung Suh, Eun Jin Jang, Songhee Cho, Ho Geol Ryu, Sungwon Na, Sang-Bum Hong, Hyun Joo Lee, Jae Yeol Kim & Sang-Min Lee. (2019) Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial. Journal of Korean Medical Science 34:14.
Crossref
P. Schuetz, A. Beishuizen, M. Broyles, R. Ferrer, G. Gavazzi, E. H. Gluck, J. Castillo, J.-U. Jensen, P. L. Kanizsai, A. Lay Hoon Kwa, S. Krueger, C.-E. Luyt, M. Oppert, M. Plebani, S. A. Shlyapnikov, G. Toccafondi, J. Townsend, T. Welte & K. Saeed. (2019) Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Laboratornaya sluzhba 8:4, pages 46.
Crossref
Luís Cabral, Vera Afreixo, Rita Meireles, Miguel Vaz, Margarida Marques, Isabel Tourais, Catarina Chaves, Luís Almeida & José Artur Paiva. (2018) Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients – a retrospective observational study. BMC Anesthesiology 18:1.
Crossref
Jennifer L. Cole. (2018) Implementation of the Procalcitonin Assay in a Rural Hospital. Hospital Pharmacy 53:6, pages 395-402.
Crossref
Sarah Sungurlu & Robert A. Balk. (2018) The Role of Biomarkers in the Diagnosis and Management of Pneumonia. Clinics in Chest Medicine 39:4, pages 691-701.
Crossref
Jennifer L. Cole & Jennifer E. Stark. (2018) Back to Basics. Infectious Diseases in Clinical Practice 26:6, pages e45-e47.
Crossref
Jennifer L. Cole. (2018) Experience during the first year of procalcitonin implementation: a precautionary tale for smaller facilities. Infection Control & Hospital Epidemiology 39:9, pages 1142-1143.
Crossref
Hae Jin Shin, Sun Hyung Kang, Hee Seok Moon, Jae Kyu Sung, Hyun Yong Jeong, Ju Seok Kim, Jong Seok Joo, Eaum Seok Lee, Seok Hyun Kim & Byung Seok Lee. (2018) Serum procalcitonin levels can be used to differentiate between inflammatory and non-inflammatory diarrhea in acute infectious diarrhea. Medicine 97:32, pages e11795.
Crossref
Irena IankovaPhilippe Thompson-LeducNoam Y. KirsonBernie RiceJuliane HeyAlexander KrauseSophie A. SchonfeldChristopher R. DeBraseSamuel BozzettePhilipp Schuetz. (2018) Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis*. Critical Care Medicine 46:5, pages 691-698.
Crossref
Philipp Schuetz, Yannick Wirz, Ramon Sager, Mirjam Christ-Crain, Daiana Stolz, Michael Tamm, Lila Bouadma, Charles E Luyt, Michel Wolff, Jean Chastre, Florence Tubach, Kristina B Kristoffersen, Olaf Burkhardt, Tobias Welte, Stefan Schroeder, Vandack Nobre, Long Wei, Heiner C Bucher, Djillali Annane, Konrad Reinhart, Ann R Falsey, Angela Branche, Pierre Damas, Maarten Nijsten, Dylan W de Lange, Rodrigo O Deliberato, Carolina F Oliveira, Vera Maravić-Stojković, Alessia Verduri, Bianca Beghé, Bin Cao, Yahya Shehabi, Jens-Ulrik S Jensen, Caspar Corti, Jos A H van Oers, Albertus Beishuizen, Armand R J Girbes, Evelien de Jong, Matthias Briel & Beat Mueller. (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. The Lancet Infectious Diseases 18:1, pages 95-107.
Crossref
Philipp Schuetz, Yannick Wirz, Ramon Sager, Mirjam Christ-Crain, Daiana Stolz, Michael Tamm, Lila Bouadma, Charles E Luyt, Michel Wolff, Jean Chastre, Florence Tubach, Kristina B Kristoffersen, Olaf Burkhardt, Tobias Welte, Stefan Schroeder, Vandack Nobre, Long Wei, Heiner C C Bucher, Neera Bhatnagar, Djillali Annane, Konrad Reinhart, Angela Branche, Pierre Damas, Maarten Nijsten, Dylan W de Lange, Rodrigo O Deliberato, Stella SS Lima, Vera Maravić-Stojković, Alessia Verduri, Bin Cao, Yahya Shehabi, Albertus Beishuizen, Jens-Ulrik S Jensen, Caspar Corti, Jos A Van Oers, Ann R Falsey, Evelien de Jong, Carolina F Oliveira, Bianca Beghe, Matthias Briel & Beat Mueller. (2017) Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews 2019:5.
Crossref
Anne Marie Dupuy, Maxence Né, Anne Sophie Bargnoux, Stéphanie Badiou & Jean Paul Cristol. (2017) Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay. Clinical Biochemistry 50:4-5, pages 248-250.
Crossref
P.J. van der Geest, M. Mohseni, D. Nieboer, S. Duran & A.B.J. Groeneveld. (2017) Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster-randomized controlled trial. Clinical Microbiology and Infection 23:2, pages 86-91.
Crossref
Ivana Stojanovic, John E. Schneider, Long Wei, Zhan Hong, Clara Keane & Philipp Schuetz. (2017) Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective. Clinical Chemistry and Laboratory Medicine (CCLM) 55:4.
Crossref
Daithi S. Heffernan. 2017. Sepsis. Sepsis 187 206 .
Pedro Póvoa, Ignacio Martin-Loeches, Paula Ramirez, Lieuwe D. Bos, Mariano Esperatti, Joana Silvestre, Gisela Gili, Gema Goma, Eugenio Berlanga, Mateu Espasa, Elsa Gonçalves, Antoni Torres & Antonio Artigas. (2016) Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study. Annals of Intensive Care 6:1.
Crossref
Marc Meili, Alexander Kutz, Matthias Briel, Mirjam Christ-Crain, Heiner C. Bucher, Beat Mueller & Philipp Schuetz. (2016) Infection biomarkers in primary care patients with acute respiratory tract infections–comparison of Procalcitonin and C-reactive protein. BMC Pulmonary Medicine 16:1.
Crossref
Yuri van der Does, Maarten Limper, Stephanie C. E. Schuit, Marten J. Poley, Joost van Rosmalen, Christian Ramakers, Peter Patka, Eric C. M. van Gorp & Pleunie P. M. Rood. (2016) Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study. BMC Emergency Medicine 16:1.
Crossref
Junyan Qu, Ping Feng, Yan Luo & Xiaoju Lü. (2016) Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease. Medicine 95:30, pages e4270.
Crossref
Soo Hyeon NohSeok Don ParkEun Jung Kim. (2016) Serum Procalcitonin Level Reflects the Severity of Cellulitis. Annals of Dermatology 28:6, pages 704.
Crossref
Se Jin AnSung Phil BaeJoon Soo ParkYoung Jin ChoiHan Hyuk LimJae Ho Lee. (2016) Antibiotic therapy decision and clinical outcome comparison based on serum procalcitonin in children with pneumonia. Allergy, Asthma & Respiratory Disease 4:1, pages 55.
Crossref
Simon W. Lam, Seth R. Bauer & Abhijit Duggal. (2016) Procalcitonin-based algorithms to initiate or stop antibiotic therapy in critically ill patients: Is it time to rethink our strategy?. International Journal of Antimicrobial Agents 47:1, pages 20-27.
Crossref
Juan Manuel Gómez-Cerquera, Rafael Daroca-Pérez, Ramón Baeza-Trinidad, Marta Casañas-Martinez, Jose Daniel Mosquera-Lozano & Enrique Ramalle-Gómara. (2015) Validity of procalcitonin for the diagnosis of bacterial infection in elderly patients. Enfermedades Infecciosas y Microbiología Clínica 33:8, pages 521-524.
Crossref
Julie Davies. (2015) Procalcitonin. Journal of Clinical Pathology 68:9, pages 675-679.
Crossref
Goran Loncar, Verena Tscholl, Elvis Tahirovic, Nikola Sekularac, Almuth Marx, Danilo Obradovic, Jovan Veskovic, Mitja Lainscak, Stephan von Haehling, Frank Edelmann, Aleksandra Arandjelovic, Svetlana Apostolovic, Dragana Stanojevic, Burkert Pieske, Tobias Trippel & Hans-Dirk Dungen. (2015) Should procalcitonin be measured routinely in acute decompensated heart failure?. Biomarkers in Medicine 9:7, pages 651-659.
Crossref
Pedro Póvoa, Ignacio Martin-Loeches & Antonio Artigas. (2015) Biomarker Kinetics in VAP. Clinical Pulmonary Medicine 22:4, pages 185-191.
Crossref
Miroslav Prucha, Geoff Bellingan & Roman Zazula. (2015) Sepsis biomarkers. Clinica Chimica Acta 440, pages 97-103.
Crossref
Deok-Ki JeongHyun-Woo LeeYoung-Min Kwon. (2015) Clinical Value of Procalcitonin in Patients with Spinal Infection. Journal of Korean Neurosurgical Society 58:3, pages 271.
Crossref
Rune Aabenhus, Jens-Ulrik S Jensen, Karsten Juhl Jørgensen, Asbjørn Hróbjartsson & Lars Bjerrum. (2014) Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database of Systematic Reviews.
Crossref
Charles-Edouard Luyt, Nicolas Bréchot, Jean-Louis Trouillet & Jean Chastre. (2014) Antibiotic stewardship in the intensive care unit. Critical Care 18:5.
Crossref
Wei Long, Li-juan Li, Gao-zhong Huang, Xue-min Zhang, Yi-cui Zhang, Jian-guo Tang, Yu Zhang & Gang Lu. (2014) Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up. Critical Care 18:5.
Crossref
Dena El-sayed, Jonathan Grotts, William A. Golgert & Alan M. Sugar. (2014) Sensitivity and Specificity of Procalcitonin in Predicting Bacterial Infections in Patients With Renal Impairment. Open Forum Infectious Diseases 1:2.
Crossref
T. Tenenbaum & J. Pöschl. (2014) Innovative Diagnostik für die pädiatrische InfektiologieInnovative diagnostics for pediatric infections. Monatsschrift Kinderheilkunde 162:8, pages 687-692.
Crossref
Fredrik Sartipy, David Lindström, Peter Gillgren & Anders Ternhag. (2014) The Role of Procalcitonin in Postimplantation Syndrome after EVAR: A Pilot Study. Annals of Vascular Surgery 28:4, pages 866-873.
Crossref
Ronald S. Chamberlain, Brian J. Shayota, Carl Nyberg & Prasanna Sridharan. (2014) The Utility of Procalcitonin as a Biomarker to Limit the Duration of Antibiotic Therapy in Adult Sepsis Patients. Surgical Science 05:08, pages 342-353.
Crossref
Roman Pfister, Matthias Kochanek, Timo Leygeber, Christian Brun-Buisson, Elise Cuquemelle, Mariana Benevides Machado, Enrique Piacentini, Naomi E Hammond, Paul R Ingram & Guido Michels. (2014) Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Critical Care 18:2, pages R44.
Crossref
Cesar Henriquez-Camacho & Juan Losa. (2014) Biomarkers for Sepsis. BioMed Research International 2014, pages 1-6.
Crossref
Daniel Drozdov, Anja Thomer, Marc Meili, Stefanie Schwarz, Rita Bossart Kouegbe, Katharina Regez, Merih Guglielmetti, Ursula Schild, Antoinette Conca, Petra Schäfer, Barbara Reutlinger, Cornelia Ottiger, Florian Buchkremer, Alexander Litke, Philipp Schuetz, Andreas Huber, Ulrich Bürgi, Christoph A Fux, Andreas Bock, Beat Müller & Werner C Albrich. (2013) Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections – ‘triple p in uti’: study protocol for a randomized controlled trial. Trials 14:1.
Crossref
Philipp Schuetz, Pierre Hausfater, Devendra Amin, Sebastian Haubitz, Lukas Fässler, Eva Grolimund, Alexander Kutz, Ursula Schild, Zeljka Caldara, Katharina Regez, Andriy Zhydkov, Timo Kahles, Krassen Nedeltchev, Stefanie von Felten, Sabina De Geest, Antoinette Conca, Petra Schäfer-Keller, Andreas Huber, Mario Bargetzi, Ulrich Buergi, Gabrielle Sauvin, Pasqualina Perrig-Chiello, Barbara Reutlinger & Beat Mueller. (2013) Optimizing triage and hospitalization in adult general medical emergency patients: the triage project. BMC Emergency Medicine 13:1.
Crossref
M de Martino & E Chiappini. (2013) Pneumonia in children: more shadows than lights. Acta Paediatrica 102, pages 1-3.
Crossref
Amal Abd El-Azeem, Gehan Hamdy, Mohamed Saraya, Esmat Fawzy, Enas Anwar & Sherif Abdulattif. (2013) The role of procalcitonin as a guide for the diagnosis, prognosis, and decision of antibiotic therapy for lower respiratory tract infections. Egyptian Journal of Chest Diseases and Tuberculosis 62:4, pages 687-695.
Crossref
João Gonçalves-Pereira. (2013) Cooperative Approach. Critical Care Medicine 41:9, pages 2226-2227.
Crossref
Esther Calbo, Luis Álvarez-Rocha, Francisco Gudiol & Juan Pasquau. (2013) A review of the factors influencing antimicrobial prescribing. Enfermedades Infecciosas y Microbiología Clínica 31, pages 12-15.
Crossref
N. Friedman. (2013) Antimicrobial Stewardship: The Need to Cover All Bases. Antibiotics 2:3, pages 400-418.
Crossref
Rodrigo Octavio Deliberato, Alexandre R. Marra, Paula Rodrigues Sanches, Marines Dalla Valle Martino, Carlos Eduardo dos Santos Ferreira, Jacyr Pasternak, Angela Tavares Paes, Lilian Moreira Pinto, Oscar Fernando Pavão dos Santos & Michael B. Edmond. (2013) Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagnostic Microbiology and Infectious Disease 76:3, pages 266-271.
Crossref
Philipp Schuetz, Beat Muller, Mirjam Christ‐Crain, Daiana Stolz, Michael Tamm, Lila Bouadma, Charles E Luyt, Michel Wolff, Jean Chastre, Florence Tubach, Kristina B Kristoffersen, Olaf Burkhardt, Tobias Welte, Stefan Schroeder, Vandack Nobre, Long Wei, Neera Bhatnagar, Heiner C Bucher & Matthias Briel. (2013) Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Evidence-Based Child Health: A Cochrane Review Journal 8:4, pages 1297-1371.
Crossref
Shih-Yang Su, Chien-Ming Chao & Chih-Cheng Lai. (2013) How About the Impact of Treatment on Procalcitonin Dynamics?. Critical Care Medicine 41:4, pages e36.
Crossref
Daniel Drozdov, Frank Dusemund, Beat Müller & Werner Albrich. (2013) Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections. Antibiotics 2:1, pages 1-10.
Crossref
Hyuck Lee. (2013) Procalcitonin as a biomarker of infectious diseases. The Korean Journal of Internal Medicine 28:3, pages 285.
Crossref
Samy Bouaicha, Samuel Blatter, Beat K. Moor, Katharina Spanaus, Claudio Dora & Clément M. L. Werner. (2013) Early Serum Procalcitonin Level after Primary Total Hip Replacement. Mediators of Inflammation 2013, pages 1-4.
Crossref
E. Cuquemelle. (2013) Infection virale sévère et surinfection bronchique chez une femme obèse. Revue des Maladies Respiratoires Actualités 5:1, pages 11-16.
Crossref
B. Planquette, A. Ferré & J. -P. Bédos. (2013) Place des micro-organismes atypiques et des virus dans les pneumonies aiguës communautaires sévèresThe role of atypical microorganisms and viruses in severe acute community-acquired pneumonia. Réanimation 22:1, pages 3-13.
Crossref
F. Dusemund, B. Bucher, S. Meyer, R. Thomann, F. Kühn, S. Bassetti, M. Sprenger, E. Baechli, T. Sigrist, M. Schwietert, D. Amin, P. Hausfater, E. Carre, P. Schuetz, J. Gaillat, K. Regez, R. Bossart, U. Schild, B. Müller & W. C. Albrich. (2012) Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. European Journal of Clinical Microbiology & Infectious Diseases 32:1, pages 51-60.
Crossref
Pedro Póvoa & Jorge I F Salluh. (2012) Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Annals of Intensive Care 2:1.
Crossref
Rune Aabenhus, Jens-Ulrik S Jensen, Karsten Juhl Jørgensen, Asbjørn Hróbjartsson & Lars Bjerrum. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
K.H. Mohamed, M.M. Abderabo, E.S. Ramadan, M.M. Hashim & S.M. Sharaf. (2012) Procalcitonin as a diagnostic marker in acute exacerbation of COPD. Egyptian Journal of Chest Diseases and Tuberculosis 61:4, pages 301-305.
Crossref
A. Sangil, E. Calbo, A. Robles, S. Benet, M. E. Viladot, V. Pascual, E. Cuchí, J. Pérez, B. Barreiro, B. Sánchez, J. Torres, L. Canales, J. A. Marcos & J. Garau. (2012) Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. European Journal of Clinical Microbiology & Infectious Diseases 31:10, pages 2765-2772.
Crossref
Philipp Schuetz, Beat Müller, Mirjam Christ-Crain, Daiana Stolz, Michael Tamm, Lila Bouadma, Charles E Luyt, Michel Wolff, Jean Chastre, Florence Tubach, Kristina B Kristoffersen, Olaf Burkhardt, Tobias Welte, Stefan Schroeder, Vandack Nobre, Long Wei, Neera Bhatnagar, Heiner C Bucher & Matthias Briel. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
D. N. Amin, J. C. Pruitt & P. Schuetz. (2012) Influence of Major Cardiopulmonary Surgery on Serum Levels of Procalcitonin and Other Inflammatory Markers. Anaesthesia and Intensive Care 40:5, pages 760-766.
Crossref
Philipp Schuetz, Matthias Briel, Mirjam Christ-Crain, Daiana Stolz, Lila Bouadma, Michel Wolff, Charles-Edouard Luyt, Jean Chastre, Florence Tubach, Kristina B. Kristoffersen, Long Wei, Olaf Burkhardt, Tobias Welte, Stefan Schroeder, Vandack Nobre, Michael Tamm, Neera Bhatnagar, Heiner C. Bucher & Beat Mueller. (2012) Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis. Clinical Infectious Diseases 55:5, pages 651-662.
Crossref
Johanna Eder, Gerald Hlavin, Alexander Haushofer, Doris Trubert-Exinger & Franz Trautinger. (2012) Correlation of serum procalcitonin with the severity of skin and skin structure infections - a pilot study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 10:8, pages 564-570.
Crossref
Philipp Schuetz & Luci K. Leykum. (2012) Procalcitonin. Hospital Medicine Clinics 1:3, pages e300-e312.
Crossref
Laura Certain & Philipp Schuetz. (2012) The Role of Procalcitonin in Respiratory Infections. Current Infectious Disease Reports 14:3, pages 308-316.
Crossref
Andrew Ustianowski. (2012) Diagnostics for community-acquired and atypical pneumonia. Current Opinion in Pulmonary Medicine 18:3, pages 259-263.
Crossref
A. Lavrentieva, S. Papadopoulou, J. Kioumis, E. Kaimakamis & M. Bitzani. (2012) PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment. Burns 38:3, pages 356-363.
Crossref
Indira Chivukula, Paul K. Marx, Kamaraju S. Ratnakar, G. Subbaiah & Venkataraman Sritharan. (2012) Serum Procalcitonin and Neutrophil Toxic Granules Guided Management of Post-Operative <i>K. pneumoniae</i> Septic-Shock in Laminectomy—A Case Report. Advances in Infectious Diseases 02:03, pages 72-75.
Crossref
Jean Carlet, Vincent Jarlier, Stephan Harbarth, Andreas Voss, Herman Goossens & Didier Pittet. (2012) Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrobial Resistance and Infection Control 1:1, pages 11.
Crossref
Andrew H. Limper. 2012. Goldman's Cecil Medicine. Goldman's Cecil Medicine 587 596 .
Philipp Schuetz, Werner Albrich & Beat Mueller. (2011) Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine 9:1.
Crossref
Tomasz Mikuła, Janusz Cianciara & Alicja Wiercińska-Drapało. (2011) Is there any influence of immune deficit on procalcitonin results?. Human Immunology 72:12, pages 1194-1197.
Crossref
Philipp Schuetz & Beat Mueller. (2011) To escalate or to de-escalte—That is the question. Critical Care Medicine 39:11, pages 2590.
Crossref
Thomas J MarrieWerner AlbrichPhilipp SchuetzBeat MüllerMirjam Christ-Crain. 2011. Primary Care Management of Community-Acquired Pneumonia. Primary Care Management of Community-Acquired Pneumonia 20 42 .
Thomas J MarrieCharles FeldmanRonald Anderson. 2011. Primary Care Management of Community-Acquired Pneumonia. Primary Care Management of Community-Acquired Pneumonia 70 83 .
Giuseppe Lippi, Tiziana Meschi & Gianfranco Cervellin. (2011) Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: Clinical evidence and perspectives. European Journal of Internal Medicine 22:5, pages 460-465.
Crossref
Thomas M. FileJr.Jr.. (2011) New Diagnostic Tests for Pneumonia: What is Their Role in Clinical Practice?. Clinics in Chest Medicine 32:3, pages 417-430.
Crossref
Charles-Edouard Luyt, Alain Combes, Jean-Louis Trouillet & Jean Chastre. (2011) Biomarkers to Optimize Antibiotic Therapy for Pneumonia Due To Multidrug-Resistant Pathogens. Clinics in Chest Medicine 32:3, pages 431-438.
Crossref
Rune Aabenhus & Jens-Ulrik Stæhr Jensen. (2011) Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?. Primary Care Respiratory Journal 20:4, pages 360-367.
Crossref
A. Breining & C. Cracco. (2011) Infections pulmonaires du sujet âgé aux urgencesPneumonia in the elderly in the emergency department. Les cahiers de l'année gérontologique 3:2, pages 56-61.
Crossref
Konrad Reinhart & Michael Meisner. (2011) Biomarkers in the Critically Ill Patient: Procalcitonin. Critical Care Clinics 27:2, pages 253-263.
Crossref
Olli Ruuskanen, Elina Lahti, Lance C Jennings & David R Murdoch. (2011) Viral pneumonia. The Lancet 377:9773, pages 1264-1275.
Crossref
René te Witt, Marlies E van Wolfswinkel, Pieter L Petit, Jaap J van Hellemond, Rob Koelewijn, Alex van Belkum & Perry JJ van Genderen. (2010) Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria. Malaria Journal 9:1.
Crossref
Konrad Reinhart & Christiane S. Hartog. (2010) Biomarkers as a guide for antimicrobial therapy. International Journal of Antimicrobial Agents 36, pages S17-S21.
Crossref
S. Pontier-Marchandise. (2010) Les pneumonies nosocomiales en 2010. Revue des Maladies Respiratoires Actualités 2:5, pages 480-483.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.